Table I.
Comparison of thyroid tests and ultrasonographic findings in men and women for two different visits
| Parameter | Female (mean ± SD) | Male (mean ± SD) | All patients (mean ± SD) | Difference (value of p)* |
|---|---|---|---|---|
| Age [years] | 51.5 ±11.36 | 57.2 ±13.4 | 52.6 ±11.96 | 0.712 |
| Hashimoto thyroiditis [%] | 32.7 | 11.1 | 28.6 | 0.018* |
| LT4 use [%] | 83.8 | 16.2 | 48.6 | 0.245 |
| 1st visit TSH [mIU/ml] | 3.2 ±3.19 | 1.42 ±1.16 | 2.85 ±2.62 | 0.063 |
| 1st visit sT3 [pmol/l] | 3.67 ±1.04 | 4.33 ±1.35 | 3.80 ±1.13 | 0.172 |
| 1st visit sT4 [pmol/l] | 16.03 ±3.72 | 16.74 ±4.15 | 16.17 ±3.81 | 0.623 |
| 1st visit anti-TG | 69.18 ±63.31 | 20.88 ±16.04 | 60.25 ±53.44 | 0.246 |
| 1st visit anti-TPO | 56.30 ±42.5 | 11.97 ±8.50 | 47.06 ±28.05 | 0.004* |
| 2nd visit TSH | 4.29 ±3.45 | 2.15 ±1.95 | 3.88 ±2.92 | 0.583 |
| 2nd visit sT3 | 3.71 ±1.49 | 3.73 ±0.94 | 3.71 ±1.39 | 0.587 |
| 2nd visit T4 | 14.62 ±4.34 | 14.92 ±3.41 | 14.68 ±4.17 | 0.697 |
| 2nd visit anti-TG | 78.30 ±76.12 | 21.46 ±19.70 | 68.13 ±64.01 | 0.865 |
| 2nd visit anti-TPO | 63.74 ±60.21 | 13.17 ±14.10 | 53.85 ±45.03 | 0.035* |
| 1st visit nodule no. | 0.89 ±0.79 | 1.00 ±0.97 | 0.91 ±0.89 | 0.685 |
| 2nd visit nodule no. | 1.15 ±1.18 | 1.00 ±1.33 | 1.12 ±1.20 | 0.784 |
| 1st visit remaining lobe volume [ml] | 9.8 ±8.2 | 12.0 ±9.11 | 10.2 ±8.4 | 0.816 |
| 2nd visit remaining lobe volume [ml] | 9.2 ±9.1 | 11.95 ±8.22 | 9.78 ±9.07 | 0.017* |
SD – standard deviation
*
statistically significant (p < 0.05)